This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Prexton Therapeutics Sa. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Beaument, FR (2019)
- Beaumont, FR (2018 - 2020)
Company Filing History:
Years Active: 2018-2020
Title: François Conquet: Innovator in Neurological Therapies
Introduction
François Conquet is a notable inventor based in Beaumont, France. He has made significant contributions to the field of neurological therapies, particularly through his innovative work on chromone oxime derivatives. With a total of 3 patents to his name, Conquet is recognized for his advancements in treating conditions related to glutamatergic signaling.
Latest Patents
Conquet's latest patents include groundbreaking inventions aimed at improving therapies for neurological disorders. One of his notable patents is a brain-penetrant chromone oxime derivative for the therapy of levodopa-induced dyskinesia. This invention provides a chromone oxime derivative that acts as a modulator of nervous system receptors sensitive to glutamate, offering high brain exposure upon oral administration. This innovation is particularly beneficial for the treatment or prevention of levodopa-induced dyskinesia and enhances therapy for Parkinson's disease when used in combination with levodopa.
Another significant patent by Conquet is a chromone oxime derivative that serves as an allosteric modulator of metabotropic glutamate receptors. This novel compound also presents high brain penetration upon oral administration. The invention includes a pharmaceutical composition containing this compound, which is intended for the treatment or prevention of conditions associated with altered glutamatergic signaling, particularly in acute and chronic neurological and psychiatric disorders.
Career Highlights
François Conquet is currently associated with Prexton Therapeutics, a company focused on developing innovative therapies for neurological diseases. His work at Prexton Therapeutics has positioned him as a key player in the field of pharmaceutical research and development.
Collaborations
Conquet collaborates with talented professionals in his field, including Delphine Charvin and Vincent Pomel. These collaborations enhance the innovative potential of his research and contribute to the advancement of neurological therapies.
Conclusion
François Conquet's contributions to the field of neurological therapies through his patents and work at Prexton Therapeutics highlight his role as a significant inventor. His innovative approaches to treating neurological disorders continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile